1. Home
  2. APYX vs MRKR Comparison

APYX vs MRKR Comparison

Compare APYX & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APYX
  • MRKR
  • Stock Information
  • Founded
  • APYX 1982
  • MRKR N/A
  • Country
  • APYX United States
  • MRKR United States
  • Employees
  • APYX N/A
  • MRKR N/A
  • Industry
  • APYX Medical/Dental Instruments
  • MRKR Biotechnology: Pharmaceutical Preparations
  • Sector
  • APYX Health Care
  • MRKR Health Care
  • Exchange
  • APYX Nasdaq
  • MRKR Nasdaq
  • Market Cap
  • APYX 42.3M
  • MRKR 35.8M
  • IPO Year
  • APYX 1987
  • MRKR N/A
  • Fundamental
  • Price
  • APYX $1.29
  • MRKR $3.50
  • Analyst Decision
  • APYX Hold
  • MRKR Strong Buy
  • Analyst Count
  • APYX 2
  • MRKR 1
  • Target Price
  • APYX N/A
  • MRKR $19.00
  • AVG Volume (30 Days)
  • APYX 59.9K
  • MRKR 34.9K
  • Earning Date
  • APYX 11-08-2024
  • MRKR 11-22-2024
  • Dividend Yield
  • APYX N/A
  • MRKR N/A
  • EPS Growth
  • APYX N/A
  • MRKR N/A
  • EPS
  • APYX N/A
  • MRKR N/A
  • Revenue
  • APYX $48,542,000.00
  • MRKR $3,727,435.00
  • Revenue This Year
  • APYX N/A
  • MRKR $35.94
  • Revenue Next Year
  • APYX $6.46
  • MRKR N/A
  • P/E Ratio
  • APYX N/A
  • MRKR N/A
  • Revenue Growth
  • APYX N/A
  • MRKR N/A
  • 52 Week Low
  • APYX $0.97
  • MRKR $2.44
  • 52 Week High
  • APYX $3.26
  • MRKR $6.16
  • Technical
  • Relative Strength Index (RSI)
  • APYX 56.25
  • MRKR 46.47
  • Support Level
  • APYX $1.11
  • MRKR $3.52
  • Resistance Level
  • APYX $1.57
  • MRKR $3.90
  • Average True Range (ATR)
  • APYX 0.13
  • MRKR 0.40
  • MACD
  • APYX 0.02
  • MRKR -0.08
  • Stochastic Oscillator
  • APYX 50.55
  • MRKR 0.00

About APYX Apyx Medical Corporation

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets. It is also developing peptide-based immunotherapeutic vaccines for the treatment of metastatic solid tumors, as well as PolyStart.

Share on Social Networks: